Streetbeat News

Regulatory

SHPH

Shuttle Pharma has opened enrollment for a Phase 2 clinical trial of Ropidoxuridine for glioblastoma at two sites. The company received FDA Orphan Drug Designation for the drug and regained Nasdaq compliance after filing delayed financial reports.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:29 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets are experiencing a mid-week relief rally, with Bitcoin attempting to recover after a recent drop. Traders suggest avoiding turning $58,300 into resistance. Notable developments include a decrease in Japan's crypto tax rate and a rise in large transaction volumes.

Portfolio Pulse from Khyathi Dalal

September 04, 2024 | 8:28 pm

LXEH

Lixiang Education Holding has received a notice from Nasdaq for non-compliance with the minimum $5 million market value rule for publicly held shares. This could lead to potential delisting if the issue is not resolved.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:26 pm

VHC

VirnetX Holding Corporation has received a noncompliance notification from the New York Stock Exchange (NYSE) due to its average closing price falling below $1.00 over a consecutive 30 trading-day period. The company has six months to regain compliance with the NYSE's continued listing standards.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:22 pm

MCHP

Microchip Technology Inc. reported a cyber incident where an unauthorized party accessed certain data from its systems. The company believes there will be no material impact on its financial condition or operations.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:22 pm

MODD

Trading for MODD was halted at 4:16:26 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:16 pm

SPY

The August jobs report is highly anticipated as investors look for signs of recovery in the U.S. labor market after July's weak figures. The July report showed a slowdown in job creation and a rise in unemployment, triggering recession fears. However, analysts from Bank of America and Goldman Sachs suggest that the situation may not indicate a recession, citing temporary factors and predicting a rebound in August. The SPDR S&P 500 ETF Trust (SPY) saw a sell-off following July's report.

Portfolio Pulse from Piero Cingari

September 04, 2024 | 8:09 pm

ATNF

180 Life Sciences has been granted a European patent for treating Dupuytren's Disease using a TNF Receptor 2 antagonist. This development could enhance their intellectual property portfolio and potentially lead to new treatment options.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:58 pm

SPY

Kamala Harris has proposed a 28% capital gains tax rate for individuals earning $1 million or more. This proposal could impact high-income investors and potentially influence market behavior.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:22 pm

MRK

Merck has received Canadian authorization for WINREVAIR (Sotatercept), the first activin signaling inhibitor therapy for treating pulmonary arterial hypertension in adults. This marks a significant milestone for Merck in expanding its product offerings in the cardiovascular space.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:01 pm